You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 16, 2024

FIORINAL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Fiorinal, and what generic alternatives are available?

Fiorinal is a drug marketed by Allergan and is included in two NDAs.

The generic ingredient in FIORINAL is aspirin; butalbital; caffeine; codeine phosphate. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the aspirin; butalbital; caffeine; codeine phosphate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FIORINAL?
  • What are the global sales for FIORINAL?
  • What is Average Wholesale Price for FIORINAL?
Summary for FIORINAL
US Patents:0
Applicants:1
NDAs:2
Raw Ingredient (Bulk) Api Vendors: 133
Drug Prices: Drug price information for FIORINAL
What excipients (inactive ingredients) are in FIORINAL?FIORINAL excipients list
DailyMed Link:FIORINAL at DailyMed
Drug patent expirations by year for FIORINAL
Drug Prices for FIORINAL

See drug prices for FIORINAL

US Patents and Regulatory Information for FIORINAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan FIORINAL aspirin; butalbital; caffeine CAPSULE;ORAL 017534-005 Apr 16, 1986 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Allergan FIORINAL aspirin; butalbital; caffeine TABLET;ORAL 017534-003 Apr 16, 1986 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Allergan FIORINAL W/CODEINE aspirin; butalbital; caffeine; codeine phosphate CAPSULE;ORAL 019429-003 Oct 26, 1990 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.